Overview

Significance of EBV Positive in Diseases

Diffuse Large B-Cell Lymphoma +

EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified +

Nasopharyngeal Carcinoma +

T-Cell/Histiocyte-Rich Large B-Cell Lymphoma +

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified +

Double-Hit Lymphoma +

Lymphoma +

Transformed Non-Hodgkin Lymphoma +

High Grade B-Cell Lymphoma, Not Otherwise Specified +

Triple-Hit Lymphoma +

Post-Transplant Lymphoproliferative Disorder +

Primary Mediastinal B-Cell Lymphoma +

ALK-Positive Large B-Cell Lymphoma +

B-Cell Non-Hodgkin Lymphoma +

Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation +

Gastric Carcinoma +

Hodgkin Lymphoma +

Malignant Solid Tumor +

Mediastinal Large B-Cell Lymphoma +

Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type +

Cancer +

Grade 3b Follicular Lymphoma +

Head And Neck Squamous Cell Carcinoma +

Lymphoproliferative Disorder +

Mature T-Cell And NK-Cell Lymphoma/Leukemia +

Nasal Type Extranodal NK/T-Cell Lymphoma +

Non-Hodgkin Lymphoma +

B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma +

Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma +

HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified +

Leiomyosarcoma +

Lymphomatoid Granulomatosis +

Non-Small Cell Lung Carcinoma +

Richter Syndrome +

Acute Lymphoblastic Leukemia +

Bladder Carcinoma +

Cervical Carcinoma +

Diffuse Large B-Cell Lymphoma Activated B-Cell Type +

Head And Neck Carcinoma +

Intravascular Large B-Cell Lymphoma +

Melanoma +

Plasmablastic Lymphoma +

Systemic EBV-Positive T-Cell Lymphoma Of Childhood +

Adenocarcinoma Of The Gastroesophageal Junction +

Anal Squamous Cell Carcinoma +

Angioimmunoblastic T-Cell Lymphoma +

Appendix Carcinoma +

Atypical Burkitt/Burkitt-Like Lymphoma +

B-Cell Acute Lymphoblastic Leukemia +

Biliary Tract Carcinoma +

Breast Carcinoma +

Burkitt Lymphoma +

Central Nervous System Lymphoma +

Cervical Squamous Cell Carcinoma +

Chronic Lymphocytic Leukemia +

Colorectal Carcinoma +

Composite Lymphoma +

EBV-Positive Mucocutaneous Ulcer +

Esophageal Squamous Cell Carcinoma +

Extranodal Marginal Zone Lymphoma Of Mucosa-Associated Lymphoid Tissue +

Follicular Dendritic Cell Sarcoma +

Follicular Lymphoma +

Gastric Adenocarcinoma +

Hemophagocytic Lymphohistiocytosis +

High Grade B-Cell Lymphoma With MYC And BCL2 And/Or BCL6 Rearrangements +

Histiocytic Sarcoma +

Immunodeficiency-Associated Lymphoproliferative Disorder +

Interdigitating Dendritic Cell Sarcoma +

Large B-Cell Lymphoma With IRF4 Rearrangement +

Malignant Pleural Mesothelioma +

Mantle Cell Lymphoma +

Merkel Cell Carcinoma +

Nodal Marginal Zone Lymphoma +

Pancreatic Carcinoma +

Peripheral T-Cell Lymphoma +

Primary Central Nervous System Lymphoma +

Primary Effusion Lymphoma +

Prostate Carcinoma +

Sarcoma +

Soft Tissue Sarcoma +

Splenic Marginal Zone Lymphoma +

Squamous Cell Carcinoma Of Unknown Primary +

Squamous Cell Carcinoma Of The Penis +

T-Cell Non-Hodgkin Lymphoma +

Urothelial Carcinoma +

Vaginal Carcinoma +

Vulvar Carcinoma +

Vulvar/Vaginal Squamous Cell Carcinoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.